Renaissance Technologies’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Renaissance Technologies’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,600	Closed	-$9K	–	4440
2023 Q1	$9K	Buy	34,600 +2,300	+7%	+$2.08K	﹤0.01%	3897
2022 Q4	$38K	Sell	32,300 -18,800	-37%	-$39.5K	﹤0.01%	3851
2022 Q3	$104K	Sell	51,100 -18,678	-27%	-$31.7K	﹤0.01%	3588
2022 Q2	$107K	Buy	+69,778	New	+$273K	﹤0.01%	3835

Renaissance Technologies's PEAR Position: Q2 2023 in Review

Renaissance Technologies sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 34,600 shares — an estimated $9K sold.

Renaissance Technologies first reported a position in PEAR in Q2 2022 and held it in 4 quarters. The position peaked at $107K in Q2 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Renaissance Technologies reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Renaissance Technologies sold 34,600 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $9K.
Renaissance Technologies first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Renaissance Technologies's Pear Therapeutics, Inc. Class A Common Stock position peaked at $107K in Q2 2022.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.